Ovarian Cancer Treatment With a Liposome Formulated mRNA Vaccine in Combination With (Neo-)Adjuvant Chemotherapy
Condition: Ovarian Cancer Intervention: Drug: W_ova1 Vaccine Sponsors: University Medical Center Groningen; Biontech RNA Pharmaceuticals GmbH Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cancer | Cancer & Oncology | Cancer Vaccines | Chemotherapy | Ovarian Cancer | Ovaries | Research | Vaccines